Skip redundant pieces
Department of Pediatrics
Pediatrics Home  :  About KU Pediatrics  :  Faculty  

Jon Scheinman, M.D.

Some of the patients seen by KU Pediatrics.
Jon Scheinman, M.D.

Interests:

  • Development of a new treatment of urinary stone disease Funded grant, covering the Phase 1 study in rats of Pyridoxamine in preventing kidney stone disease. Writing, Phase II – clinical of above.

Related Info

List of Faculty

Faculty by Division

Pediatric Divisions

Specialty:
 Pediatric Nephrology
Position:
 Professor of Pediatrics,
Chief, Pediatric Nephrology Division
E-Mail:
 jscheinman@kumc.edu
Telephone:
 913-588-6031
Facsimile:
 913-588-2253
Office Location:
 G011 Miller
Mailing Address:
 Mail Stop 4004
3901 Rainbow Blvd
Kansas City, KS  66160
Pager:
 913-917-3598 (After tone, enter callback number and press '#')
Web Pager:
 http://Airtouch.com

Education & Training:

  • Undergraduate: BA (Biology), Wesleyan University, Middletown CT;
  • Graduate: M.D., University of Illinois College of Medicine, Chicago, IL;
  • Internship: Pediatrics, University Colorado Med Center, Denver, CO;
  • Residency:
    • Pediatrics, University of Iowa Hospital, Iowa City, IA;
    • Pediatrics, University Wisconsin Hospital, Madison, WI;
  • Fellowship:Pediatric Nephrology, University of Minnesota Hospital, Minneapolis, MN.

Licensure and Certification:

  • Licensed in Kansas, Virginia, and North Carolina;
  • American Board of Pediatrics;
  • American Board of Pediatrics Sub-Board in Pediatric Nephrology.

Professional Societies:

  • American Society of Pediatric Nephrology (Founding Member);
  • American Association of Pathologists;
  • American Association of Nephrology;
  • American Heart Association & Council on Kidney in Cardiovascular Disease;
  • International Society of Nephrology;
  • International Society of Pediatric Nephrology;
  • Hyperoxaluria Oxalosis Foundation;
  • American Heart Association – Council on Kidney Diseases.

Awards:

  • 1974-1975 Fellowship, Minnesota Heart Association;
  • 1975-1980 NIH Research Career Development Award;
  • 1998-2002. Section Editors . Distinguished Scientists Lecture Series.

Previous Professional Service:

  • 1983-1991 Chairman, Pediatric Nephrology Division, Duke University, Durham, NC.
  • 1995-1996 Chair, Pediatric QA&I committee, VCU/MCV, Richmond, VA.
  • 1994-1996 Chairman, Pediatric Quality Assurance and Improvement Committee, VCU/MCV, Richmond, VA.
  • 1999 (KUMC) Various Pediatric Departmental Committees.
  • 1992-Present Editorial Reviewer, ad hoc, Pediatric Nephrology.
  • 1992-Present Editorial Reviewer, ad hoc, Kidney International.
  • 1994-Present Editorial Reviewer, ad hoc, J. Am. Soc Ped. Nephrology.
  • 2001- 2003 KU Education Council, Pediatric Representative.

Publications:

Presentations:

  • Scheinman JI, Fallon MD, Small KW, Mahan JD, Letson RD, and Klintworth GK: Primary hyperoxaluria (PHO): Common mitogenic effects on bone and retina. VIII Congress Int Ped Nephrol Assoc, Toronto, Canada (Aug 28) 1989.
  • Scheinman JI, Fallon M, Mahan J: Quantitative bone histomorphometry in oxalosis serial biopsy analysis. National Kidney Foundation, Washington, DC (Dec) 1989.
  • Scheinman JI, Tanaka H, Brown O: Collagan mRNA analysis in human and porcine glomerular and tubular cells shows cell specialization in vitro. Amer Soc Nep hrol, Washington, DC, 1989.
  • Scheinman JI, Alexander M, Campbell ED, Chan JC, Latta K, Cochat P, Katz A: Transplanta-tion for primary hyperoxaluria in the U.S.A. Annual Meeting, American Pediatric Society/Society Pediatric Research, San Diego, CA, May 7-11, 1995.
  • Scheinman JI: Results of isolated kidney and kidney/liver transplantation in PH1. Oxalosis Hyperoxaluria Foundation, Satellite meeting to ASN, November 4, 1996
  • Scheinman JI, Katz A, Hoppe B, Chan JCC. Transplantation for Primary Hyperoxaluria in the U.S. Presented at 4th. Int Workshop on Primary Hyperoxaluria, Torino, Italy , March 1997.
  • Scheinman JI: Results of isolated kidney and kidney/liver transplantation in PH1. Oxalosis Hyperoxaluria Foundation, Satellite meeting to AmSoc Ped Nephrol. May, 1997.
  • Saborio P, Hoppe B, Katz A, Chan JCM, and Scheinman JI, M.D. Transplantation for Primary Hyperoxaluria (PH) in the USA J Am Soc Nephrol 9:695a, 1998. ASN, 25 Oct 98 poster session S893, and Free Communications, de novo and recurrent diseases of allografts. T1112, 27 Oct 98.
  • Saborio P and Scheinman JI, M.D. Transplantation for Primary Hyperoxaluria (PH) in the USA : Results of isolated kidney (KTX) and combined kidney/liver transplantation (K/LTX). 4th International Workshop on Primary Hyperoxaluria, Zurich, Switzerland, 11-13 Mar, 1999.
  • Scheinman, J.I. Pitfalls in Database analysis of USRDS Data on Transplantation. NIH Workshop on Primary Hyperoxalutia, 15-17 Nov 2000.
  • Chan JCC, Mahan JD, Trachtman H, Scheinman JI , Flynn JT, Alon U, Lande MB, Weiss RA. Outcome of Vitamin E Treatment on the Progression of IgA Nephropathy : A Double-blind Placebo controlled, Randomized Clinical Trial in children. American Pediatric Society, Platform Session 04 May 02
  • Scheinman JI, Payne R, Boothe A. Management of ESRD in Primary Hyperoxaluria (PH) in the USA in 2001: Results of Dialysis, Kidney and Kidney/Liver Transplantation. European Workshop on Hyperoxaluria 5-6 April, 2002.
  • Scheinman JI. Sickle Cell Nephropathy; Physiology and Therapy. Plenary Address. American Pediatric Society, Baltimore MD, Platform Session 05 May 02.
  • Scheinman JI. Management of ESRD in Primary Hyperoxaluria in the U.S.A. in 2001: Results of Dialysis, Kidney and Combined Kidney/Liver Transplantation. 6th European Workshop on Hyperoxaluria, 05. - 06. April 2002, Hannover, Germany.
  • Irith Weissman, Jon Scheinman., Chairs. Treatment and special aspects of Primary Hyperoxaluria. 6th European Workshop on Hyperoxaluria, 05. - 06. April 2002, Hannover, Germany.
  • Saborio P, Hoppe B, Katz A, Chan JCM, and Scheinman JI, M.D. Transplantation for Primary Hyperoxaluria (PH) in the USA J Am Soc Nephrol 9:695a, 1998. ASN, 25 Oct 98 poster session S893, and Free Communications, de novo and recurrent diseases of allografts. T1112, 27 Oct 98.
  • Scheinman JI, Boothe A. Management of ESRD in Primary Hyperoxaluria (PH) in the USA in 2001: Results of Dialysis, Kidney and Kidney/Liver Transplantation. International Congress of Pediatric Nephrology, Seattle WA 1-5 Sept 2001.
  • Scheinman JI, Boothe A. Management of ESRD in Primary Hyperoxaluria (PH) in the USA in 2001: Results of Dialysis, Kidney and Kidney/Liver Transplantation. ASN/ISN World Congress of Nephrology San Francisco CA, 14 Oct 2001. Pub A1251.
  • Scheinman, JI and Payne, R. ESRD in Sickle Cell Nephropathy, survival with and without transplantation. American Society of Nephrology, 1 Nov 02. Philadelphia PA. JASN 13:403A.
  • Chetyrkin S, Kim d, Scheinman JI, Hudson B, Voziyan P. A New Method for Treatment of Hyperoxalurias and Kidney Stone Disease. American Society of Nephrology, 2 Nov 02. Philadelphia PA. JASN 13: 574A.
  • Chetyrkin S, Belmont J, Scheinman JI, Hudson B, Voziyan P. A New Method for Treatment of Hyperoxalurias and Kidney Stone Disease: Pyridoxamine Inhibits Kidney Crystal Formation in Hyperoxaluric Rats. American Society of Nephrology, 16 Nov 03. San Diego CA. JASN 14: (Poster SU-PO754).
  • Scheinman, JI and Payne, R. ESRD in Sickle Cell Nephropathy, survival with and without transplantation. American Society of Nephrology, 1 Nov 02. Philadelphia PA. JASN 13:403A.
  • Chetyrkin S, Kim d, Scheinman JI, Hudson B, Voziyan P. A New Method for Treatment of Hyperoxalurias and Kidney Stone Disease. American Society of Nephrology, 2 Nov 02. Philadelphia PA. JASN 13: 574A.
  • Scheinman JI, Payne R, Boothe A. Management of ESRD in Primary Hyperoxaluria (PH) in the USA in 2001: Results of Dialysis, Kidney and Kidney/Liver Transplantation. European Workshop on Hyperoxaluria 5-6 April, 2002.
  • Scheinman JI. Sickle Cell Nephropathy; Physiology and Therapy. Plenary Address. American Pediatric Society, Baltimore MD, Platform Session 05 May 02.
  • Scheinman JI. Management of ESRD in Primary Hyperoxaluria in the U.S.A. in 2001: Results of Dialysis, Kidney and Combined Kidney/Liver Transplantation. 6th European Workshop on Hyperoxaluria, 05. - 06. April 2002, Hannover, Germany, Irith Weissman, Jon Scheinman, Chairs.
  • Invited Speaker, NIH conference on Primary Hyperoxaluria (19-21 Nov 03)
    Scheinman, J.I. Pyridorin, an effective trap for the precursors of oxalate biosynthesis, glyoxylate and glycolaldehyde, decreases oxalate excretion and neprolithiasis in rats. Invited Speaker, 7th International Workshop on Hyperoxaluria, 8-10 Oct 2004, Rochester MN

Current and Recent Grant Funding:

  • Grant Number: 1 R41 DK60251-01A1
    P.I. VOZIYAN, PAUL A PHD,
    Co Investigator, Jon I Scheinman NIH/STTR $100,000 2002-2003 Funded
    Project Title: Development of a new treatment of urinary stone disease
  • Patent awarded to KUMC # US 6,521,645 B2.
    Inventors. Paul Voziyan, Billy Hudson, Jon Scheinman.
  • International collaborative study of Focal Segmental Glomerulosclerosis
    Hogg, Ron. (PI)
    Scheinman, JI (Co-Investigator) NIH $4500/subject, 2005-2009, Active
  • Effect of Pyridoxamine on Hyperoxaluria of Stone Disease.
    Scheinman, JI (PI) NIH-R21 $275,000 2006-2007 Pending
  • Vitamin E Modulates IgA Nephropathy Collaborative Study.
    Chan, James (PI)
    Scheinman, JI (Collaborative Investigator) NIH-R01 $579,924 Pending
top of page